Elisa Barbieri 4/3/25 Elisa Barbieri 4/3/25

Alpenglow Biosciences Expands Advisory Board with Two Esteemed Industry Leaders

Alpenglow Biosciences expands its Advisory Board with the addition of industry leaders Blandine Merino, M.S., and Mike Rice, joining Jesse Salk, M.D., Ph.D. Their combined expertise in digital pathology, AI-driven cancer detection, and life sciences will accelerate the company’s growth and innovation in precision medicine.

Elisa Barbieri 3/20/25 Elisa Barbieri 3/20/25

Alpenglow Biosciences Introduces LUMI: A Breakthrough Imaging Interface

Elisa Barbieri 3/6/25 Elisa Barbieri 3/6/25

Alpenglow Biosciences and Incyte Corporation to Present 3D Imaging Research at SID 2025

Alpenglow Biosciences and Incyte Corporation will present groundbreaking 3D imaging research at SID 2025, showcasing how 3D imaging reveals neuroimmune dynamics in atopic dermatitis treated with ruxolitinib cream. Using Alpenglow’s Aurora 3Di light-sheet microscopy, the study provides unprecedented insights into nerve volume, immune cell distribution, and epidermal remodeling.

Elisa Barbieri 2/27/25 Elisa Barbieri 2/27/25

We Announce Our ePoster Presentation at SID

Elisa Barbieri 2/11/25 Elisa Barbieri 2/11/25

Alpenglow Biosciences CEO Nick Reder shared his insights on NIH funding cuts in the Washington Post.

Elisa Barbieri 11/19/24 Elisa Barbieri 11/19/24

Alpenglow Biosciences is Recognized as a rising Leader in 3D Spatial Biology.

Elisa Barbieri 11/11/24 Elisa Barbieri 11/11/24

Alpenglow Biosciences CEO Nick Reder, MD, MPH, to Present at the Dermatology Summit 2025

Elisa Barbieri 11/5/24 Elisa Barbieri 11/5/24

Poster presentation at Multi-Omics Brisbane 2024

Elisa Barbieri 10/24/24 Elisa Barbieri 10/24/24

Dinner Lecture at SITC24 by Prof. Pei-Ling Chen: “Spatially resolved immunologic hallmarks of response to immune checkpoint blockade therapies in metastatic melanoma in 2D and 3D.”

Elisa Barbieri 10/2/24 Elisa Barbieri 10/2/24

Final Agenda Announced for the 3D Spatial Summit 2024: Join Leading Academics and Industry Experts on October 17th in Cambridge, MA

Elisa Barbieri 8/15/24 Elisa Barbieri 8/15/24

Alpenglow Biosciences Secures $24M+ in ARPA-H and NIH Contracts to Revolutionize Cancer and Prostate Diagnostics

Guest User 3/12/24 Guest User 3/12/24

Win a $50,000 3D I/O Pro™ research grant from Alpenglow

Alpenglow unveils a $50,000 research grant program for novel applications of its brand new 3D I/O Pro assay. Unlock insights into the tumor microenvironment with whole tissue 3D imaging and analysis.

Steve Pemberton 2/6/24 Steve Pemberton 2/6/24

Alpenglow Biosciences Announces Immediate Availability of 3D Derm Score Assay for Research into complex diseases of the skin

We have developed the 3D Derm Score Assay to reveal the complexities of the skin microenvironment and determine the relationship between critical structures in the epidermis and dermis.

Guest User 10/30/23 Guest User 10/30/23

Alpenglow Biosciences, Inc. Sponsors Dinner Lecture titled “Decoding Immune Exclusion and Tumor Evasion in the TME”, featuring Dr. Laura Dillon, PhD of Incendia Therapeutics

Alpenglow Biosciences sponsors dinner lecture titles “Decoding Immune Exclusion and Tumor Evasion in the TME” during the 2023 annual SITC meeting

Guest User 8/29/23 Guest User 8/29/23

Announcing the 3D Spatial Summit, an inaugural event for the field of 3D Spatial Biology on September 21, 2023 in Cambridge, Massachusetts

Alpenglow Biosciences presents the 3D Spatial Summit, an inaugural event for the field of 3D Spatial Biology to take place on September 21, 2023 in Cambridge, Massachusetts